MedPath

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome

Phase 1
Completed
Conditions
Human Volunteers
Interventions
Device: Tourniquet
Device: INVOS assessment
Device: EMG assessment
Registration Number
NCT01452425
Lead Sponsor
Université Catholique de Louvain
Brief Summary

Muscular compartment syndrome (MCS) is consecutive to an increase in intramuscular compartment pressures, and is a rare but serious postoperative complication.

The INVOS (In Vivo Optical Spectroscopy) monitors tissular oxygenation continuously and non-invasively.

The objective is to develop a model mimicking the physiopathology of MCS to assess the interest of the INVOS in this case.

Detailed Description

After inflation of a tourniquet (pressure equal to the mean arterial pressure, we will obtain a model of slight venous congestion and arterial hypoperfusion. A comparison will be made between INVOS monitoring, sensory deficits, pain, electromyography and invasive pressure.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
10
Inclusion Criteria
  • Healthy volunteers
  • >18yr
  • Informed consent
  • Male
Exclusion Criteria
  • Neuropathies
  • Vascular pathology
  • Actual pain
  • Anti-platelet or anticoagulant therapy
  • Ipsilateral history of fracture

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TourniquetEMG assessmentInflation of a tourniquet
TourniquetTourniquetInflation of a tourniquet
TourniquetINVOS assessmentInflation of a tourniquet
Primary Outcome Measures
NameTimeMethod
Intracompartmental Pressure (ICP)45 minutes

\[mean (SD)\] ICP (in mmHg), value at baseline and at the time of the block

Comparison Between INVOS Monitoring and Electromyography45 minutes

A comparison will be made between the INVOS monitoring and non invasive (transcutaneous) EMG monitoring (AP Block), to determine the accuracy of the INVOS monitoring to predict AP block.

Measures were:

\[mean (SD)\] INVOS (in %) value at baseline and at the time of the block

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cliniques universitaires Saint-Luc

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath